199 related articles for article (PubMed ID: 38290972)
41. The FACT complex facilitates expression of lysosomal and antioxidant genes through binding to TFEB and TFE3.
Jeong E; Martina JA; Contreras PS; Lee J; Puertollano R
Autophagy; 2022 Oct; 18(10):2333-2349. PubMed ID: 35230915
[TBL] [Abstract][Full Text] [Related]
42. TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer.
Lin HY; Kuei CH; Lee HH; Lin CH; Chen YL; Chen CL; Lin YF
J Mol Med (Berl); 2020 Sep; 98(9):1255-1267. PubMed ID: 32671412
[TBL] [Abstract][Full Text] [Related]
43. (R)-9bMS Inhibited the Protein Synthesis and Autophagy of Triple Negative Breast Cancer Cells
Bai X; Han G; Li F; Li W; Bu P; Zhang H; Xie J
Protein Pept Lett; 2023; 30(4):295-303. PubMed ID: 36861798
[TBL] [Abstract][Full Text] [Related]
44. Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model.
Andey T; Marepally S; Patel A; Jackson T; Sarkar S; O'Connell M; Reddy RC; Chellappan S; Singh P; Singh M
J Control Release; 2014 Jun; 184():67-78. PubMed ID: 24727000
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.
Lefort S; Joffre C; Kieffer Y; Givel AM; Bourachot B; Zago G; Bieche I; Dubois T; Meseure D; Vincent-Salomon A; Camonis J; Mechta-Grigoriou F
Autophagy; 2014; 10(12):2122-42. PubMed ID: 25427136
[TBL] [Abstract][Full Text] [Related]
46. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
[TBL] [Abstract][Full Text] [Related]
47. PYCR3 modulates mtDNA copy number to drive proliferation and doxorubicin resistance in triple-negative breast cancer.
Zhuang F; Huang S; Liu L
Int J Biochem Cell Biol; 2024 Jun; 171():106581. PubMed ID: 38642827
[TBL] [Abstract][Full Text] [Related]
48. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.
Gibbs LD; Vishwanatha JK
Oncotarget; 2018 Jan; 9(2):2697-2704. PubMed ID: 29416802
[TBL] [Abstract][Full Text] [Related]
49. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
[TBL] [Abstract][Full Text] [Related]
50. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
Zhang M; Kim HS; Jin T; Moon WK
J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
[TBL] [Abstract][Full Text] [Related]
51. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells.
Das S; Shetty P; Valapala M; Dasgupta S; Gryczynski Z; Vishwanatha JK
Biochemistry; 2010 Mar; 49(10):2216-26. PubMed ID: 20121258
[TBL] [Abstract][Full Text] [Related]
52. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.
Shetty PK; Thamake SI; Biswas S; Johansson SL; Vishwanatha JK
PLoS One; 2012; 7(9):e44299. PubMed ID: 22957061
[TBL] [Abstract][Full Text] [Related]
53. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
[TBL] [Abstract][Full Text] [Related]
54. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM
PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519
[TBL] [Abstract][Full Text] [Related]
55. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
56. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
57. Autophagy drives fibroblast senescence through MTORC2 regulation.
Bernard M; Yang B; Migneault F; Turgeon J; Dieudé M; Olivier MA; Cardin GB; El-Diwany M; Underwood K; Rodier F; Hébert MJ
Autophagy; 2020 Nov; 16(11):2004-2016. PubMed ID: 31931659
[TBL] [Abstract][Full Text] [Related]
58. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C
Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028
[TBL] [Abstract][Full Text] [Related]
60. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]